Acid Tranexamic Kabi

Acid Tranexamic Kabi is a pharmaceutical product containing tranexamic acid, used for its anticoagulant properties. This intravenous solution is manufactured by Fresenius Kabi Romania Srl and is suitable for various medical applications.

Tranexamic acid is commonly used to manage excessive bleeding by inhibiting the breakdown of blood clots. It is often administered intravenously to support hemostasis in surgical procedures or to treat conditions associated with abnormal bleeding. Tranexamic acid works by stabilizing clots, making it useful in scenarios where rapid blood loss control is necessary.

When administered intravenously, tranexamic acid can help reduce blood loss and promote clotting. Patients may experience a decrease in bleeding episodes and improved stability in conditions where excessive bleeding is a concern. The effects are typically observed within a short period after administration, providing quick relief in critical situations.

Tranexamic acid should be used with caution in patients with a history of blood clots or thromboembolic events. It is important to follow medical guidance when administering this medication to avoid potential complications. Patients should be monitored for any signs of adverse reactions, and the medication should be stored and handled according to the manufacturer's instructions.

Tranexamic acid may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Additionally, patients should be cautious when consuming alcohol or other substances that may affect blood clotting while using tranexamic acid.